S100A8 and inflammatory bowel disease: S100A8/9 is used as a marker of inflammation activity and as a predictor of the subsequent course of IBDs; in particular, fecal calprotectin testing has been applied to revolutionize IBD clinical practice with a role in differentiating IBD from functional gut disorders (129).